Literature DB >> 23611880

GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.

Linda Leivseth1, Ben Michael Brumpton, Tom Ivar Lund Nilsen, Xiao-Mei Mai, Roar Johnsen, Arnulf Langhammer.   

Abstract

BACKGROUND: How different Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifications of chronic obstructive pulmonary disease (COPD) predict mortality is unclear.
OBJECTIVE: To examine the association of spirometric GOLD grades and the new ABCD groups with mortality, and to compare their informativeness in relation to mortality.
METHODS: We studied 1540 people with post-bronchodilator COPD who participated in the Norwegian Nord-Trøndelag Health Study 1995-1997 and were followed up on all-cause mortality until May 2012. The associations of spirometric GOLD grades and ABCD groups with mortality were estimated by sex specific adjusted HRs from Cox regression and standardised mortality ratios. To assess the informativeness of spirometric GOLD grades and ABCD groups at predicting mortality we used the difference in twice the log-likelihood of a Cox regression model with and without each COPD classification.
RESULTS: The distribution of participants was 28% in GOLD 1, 57% in GOLD 2, 13% in GOLD 3 and 2% in GOLD 4, in contrast to 61% in group A, 18% in group B, 12% in group C and 10% in group D. During a median of 14.6 years of follow-up, 837 people (54%) died. Mortality increased gradually from GOLD 1 to 4, while it was generally similar in groups A and B, and in groups C and D. Spirometric GOLD grades were substantially more informative than ABCD groups at predicting mortality.
CONCLUSIONS: Spirometric GOLD grades predicted mortality better than the new ABCD groups among people with COPD from a Norwegian general population.

Entities:  

Keywords:  COPD Exacerbations; COPD epidemiology

Mesh:

Year:  2013        PMID: 23611880     DOI: 10.1136/thoraxjnl-2013-203270

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey.

Authors:  Young Seok Lee; Kyung Hoon Min; Chin Kook Rhee; Yong Hyun Kim; Seong Yong Lim; Soo-Jung Um; Chang-Hoon Lee; Ki-Suck Jung; Kwang Ha Yoo
Journal:  Lung       Date:  2019-03-11       Impact factor: 2.584

2.  Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Haiquan Huang; Georges Nakhoul; Stacey E Jolly; Susana Arrigain; Raed A Dweik; Joseph V Nally
Journal:  Am J Nephrol       Date:  2016-02-19       Impact factor: 3.754

3.  Prevalence And Impact of Medical Comorbidities in A Real-World Lung Cancer Screening Population.

Authors:  Harris Majeed; Hong Zhu; Sarah A Williams; Heidi A Hamann; Vijaya Subbu Natchimuthu; Jessica Lee; Noel O Santini; Travis Browning; Tanushree Prasad; Joyce O Adesina; Minh Do; David Balis; Juana Gamarra de Willams; Ellen Kitchell; David H Johnson; Simon J Craddock Lee; David E Gerber
Journal:  Clin Lung Cancer       Date:  2022-04-29       Impact factor: 4.840

Review 4.  [Anesthesia in a patient after endoscopic lung volume reduction. First anesthesiological experiences with implanted endobronchial valves].

Authors:  P Hilbert; K-P Litwinenko; B Niemann; K zur Nieden
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

5.  Feasibility and effectiveness of an asthma/COPD service for primary care: a cross-sectional baseline description and longitudinal results.

Authors:  Esther I Metting; Roland A Riemersma; Janwillem H Kocks; Margriet G Piersma-Wichers; Robbert Sanderman; Thys van der Molen
Journal:  NPJ Prim Care Respir Med       Date:  2015-01-08       Impact factor: 2.871

6.  Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.

Authors:  Joohae Kim; Ho Il Yoon; Yeon-Mok Oh; Seong Yong Lim; Ji-Hyun Lee; Tae-Hyung Kim; Sang Yeub Lee; Jin Hwa Lee; Sang-Do Lee; Chang-Hoon Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-07

7.  Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Dong Liu; Shao-Hua Peng; Jing Zhang; Si-Hong Bai; Hai-Xia Liu; Jie-Ming Qu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-02

8.  Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.

Authors:  Mireia Raluy-Callado; Dimitra Lambrelli; Sharon MacLachlan; Javaria Mona Khalid
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-13

9.  New GOLD classification: longitudinal data on group assignment.

Authors:  Ciro Casanova; Jose M Marin; Cristina Martinez-Gonzalez; Pilar de Lucas-Ramos; Isabel Mir-Viladrich; Borja Cosio; German Peces-Barba; Miryam Calle-Rubio; Ingrid Solanes-García; Ramón Agüero; Alfredo de Diego-Damia; Nuria Feu-Collado; Inmaculada Alfageme; Rosa Irigaray; Eva Balcells; Antonia Llunell; Juan Bautista Galdiz; Margarita Marín; Juan José Soler-Cataluña; Jose Luis Lopez-Campos; Joan B Soriano; Juan P de-Torres
Journal:  Respir Res       Date:  2014-01-13

10.  The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.

Authors:  Qing Song; Yi-Yang Zhao; Yu-Qin Zeng; Cong Liu; Wei Cheng; Min-Hua Deng; Xin Li; Li-Bing Ma; Yan Chen; Shan Cai; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.